Alyson Goldstein, PSYD in Appleton, ME - Psychologist

Alyson Goldstein, PSYD is a Psychologist based in Appleton, Maine. Alyson Goldstein is licensed to practice in Maine (license number PS2462) and her current practice location is 26 Camden Rd, Appleton, Maine. She can be reached at her office (for appointments etc.) via phone at (610) 306-9926.

NPI number for Alyson Goldstein is 1255068268 and her current mailing address is 26 Camden Rd, Appleton, Maine. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1255068268.

Contact Information

	Alyson Goldstein, PSYD
	26 Camden Rd, Appleton, ME 04862-6420
	(610) 306-9926
	Not Available

Healthcare Provider's Profile

Full Name	Alyson Goldstein
Gender	Female
Speciality	Psychologist
Location	26 Camden Rd, Appleton, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1255068268
Provider Enumeration Date: 08/01/2022
Last Update Date: 08/01/2022

Medical Identifiers

Medical identifiers for Alyson Goldstein such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255068268	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	PS019304 (Pennsylvania)	Secondary
103T00000X	Psychologist	PS2462 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alyson Goldstein is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alyson Goldstein, PSYD 26 Camden Rd, Appleton, ME 04862-6420 Ph: (610) 306-9926	Alyson Goldstein, PSYD 26 Camden Rd, Appleton, ME 04862-6420 Ph: (610) 306-9926

News Archive

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.

Penn's Radiation Oncology department provides VR mindfulness experience for patients

As your eyes scan the horizon, the starry nightscape gives way to the first hints of light as the sun peeks above the point where the ocean meets the sky. As the sun rises over the water, you glance to your right and notice a swing hanging from a tree that's lightly rocking in the gentle breeze, a breeze you can hear as it rustles leaves and calmly plays through the wind chimes on the deck of the house nearby.

Scientists discover network for molecular communication in human embryonic stem cells

Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state.

New guidelines on management and return to play of Female Athlete Triad discussed at AMSSM

The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves three components: low energy availability with or without disordered eating, menstrual dysfunction and low bone mineral density.

UGA investigators find viable treatment for prostate cancer

Researchers at the University of Georgia have created a new therapeutic for prostate cancer that has shown great efficacy in mouse models of the disease. They published their findings recently in the journal Nanomedicine: Nanotechnology, Biology and Medicine.

Alyson Goldstein, PSYD - Psychologist in Appleton, ME